• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4644043)   Today's Articles (1660)   Subscriber (50654)
For: Twelves CJ, Dobbs NA, Lawrence MA, Ramirez AJ, Summerhayes M, Richards MA, Towlson KE, Rubens RD. Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life. Br J Cancer 1994;69:726-31. [PMID: 8142261 PMCID: PMC1968796 DOI: 10.1038/bjc.1994.137] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]  Open
Number Cited by Other Article(s)
1
Binmujlli MA. Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications. Molecules 2024;29:4203. [PMID: 39275052 PMCID: PMC11397058 DOI: 10.3390/molecules29174203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2024] [Revised: 08/29/2024] [Accepted: 09/03/2024] [Indexed: 09/16/2024]  Open
2
Binmujlli MA. Radiological and Molecular Analysis of Radioiodinated Anastrozole and Epirubicin as Innovative Radiopharmaceuticals Targeting Methylenetetrahydrofolate Dehydrogenase 2 in Solid Tumors. Pharmaceutics 2024;16:616. [PMID: 38794278 PMCID: PMC11126143 DOI: 10.3390/pharmaceutics16050616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2024] [Revised: 04/13/2024] [Accepted: 04/18/2024] [Indexed: 05/26/2024]  Open
3
Anasamy T, Thy CK, Lo KM, Chee CF, Yeap SK, Kamalidehghan B, Chung LY. Tribenzyltin carboxylates as anticancer drug candidates: Effect on the cytotoxicity, motility and invasiveness of breast cancer cell lines. Eur J Med Chem 2017;125:770-783. [DOI: 10.1016/j.ejmech.2016.09.061] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2016] [Revised: 09/19/2016] [Accepted: 09/20/2016] [Indexed: 12/14/2022]
4
Smyth EN, Shen W, Bowman L, Peterson P, John W, Melemed A, Liepa AM. Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health Qual Life Outcomes 2016;14:52. [PMID: 27016084 PMCID: PMC4807577 DOI: 10.1186/s12955-016-0449-z] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2015] [Accepted: 03/09/2016] [Indexed: 12/16/2022]  Open
5
Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : CR 2008;27:32. [PMID: 18759983 PMCID: PMC2543010 DOI: 10.1186/1756-9966-27-32] [Citation(s) in RCA: 470] [Impact Index Per Article: 29.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 08/08/2008] [Accepted: 08/29/2008] [Indexed: 02/06/2023]
6
Han X, Twamley B, Natale NR. Preparation of 3-(10′-halo-9′-anthracenyl) isoxazolecarboxylic esters. J Heterocycl Chem 2003. [DOI: 10.1002/jhet.5570400321] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
7
Dobbs NA, Twelves CJ, Gregory W, Cruickshanka C, Richards MA, Rubens RD. Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification scheme. Eur J Cancer 2003;39:580-6. [PMID: 12628836 DOI: 10.1016/s0959-8049(02)00669-x] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
8
Danesi R, Fogli S, Gennari A, Conte P, Del Tacca M. Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Clin Pharmacokinet 2002;41:431-44. [PMID: 12074691 DOI: 10.2165/00003088-200241060-00004] [Citation(s) in RCA: 140] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
9
Stephens RJ, Hopwood P, Girling DJ. Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise. Br J Cancer 1999;79:538-44. [PMID: 10027327 PMCID: PMC2362419 DOI: 10.1038/sj.bjc.6690085] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]  Open
10
Ramirez AJ, Towlson KE, Leaning MS, Richards MA, Rubens RD. Do patients with advanced breast cancer benefit from chemotherapy? Br J Cancer 1998;78:1488-94. [PMID: 9836482 PMCID: PMC2063215 DOI: 10.1038/bjc.1998.711] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]  Open
11
Dobbs NA, Twelves CJ. What is the effect of adjusting epirubicin doses for body surface area? Br J Cancer 1998;78:662-6. [PMID: 9744507 PMCID: PMC2063057 DOI: 10.1038/bjc.1998.556] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
12
Johnson SA, Richardson DS. Anthracyclines in haematology: pharmacokinetics and clinical studies. Blood Rev 1998;12:52-71. [PMID: 9597198 DOI: 10.1016/s0268-960x(98)90030-3] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
13
Yabroff KR, Linas BP, Schulman K. Evaluation of quality of life for diverse patient populations. Breast Cancer Res Treat 1996;40:87-104. [PMID: 8888155 DOI: 10.1007/bf01806005] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
14
Cherny NI, Catane R. Palliative medicine and the medical oncologist. Defining the purview of care. Hematol Oncol Clin North Am 1996;10:1-20. [PMID: 8821557 DOI: 10.1016/s0889-8588(05)70324-5] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
15
Berger I, Su L, Spitzner JR, Kang C, Burke TG, Rich A. Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d(TGTACA) and d(CGATCG). Nucleic Acids Res 1995;23:4488-94. [PMID: 7501474 PMCID: PMC307408 DOI: 10.1093/nar/23.21.4488] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]  Open
16
Dobbs NA, Twelves CJ, Gillies H, James CA, Harper PG, Rubens RD. Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry. Cancer Chemother Pharmacol 1995;36:473-6. [PMID: 7554038 DOI: 10.1007/bf00685796] [Citation(s) in RCA: 78] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
17
Breast Cancer Treatment LiteratureWatch. J Womens Health (Larchmt) 1994. [DOI: 10.1089/jwh.1994.3.317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
18
Dobbs NA, Twelves CJ, Rizzi P, Warwick JD, Metivier EM, Williams R, Johnson PJ. Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activity. Cancer Chemother Pharmacol 1994;34:405-10. [PMID: 8070007 DOI: 10.1007/bf00685565] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA